Tetanus

Showing 1 - 25 of 204

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tetanus Trial in Bijie (TTVA, TT)

Not yet recruiting
  • Tetanus
  • TTVA
  • TT
  • Bijie, Guizhou, China
    Center for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023

Tetanus Trial in Bijie (TTVA, TT)

Not yet recruiting
  • Tetanus
  • TTVA
  • TT
  • Bijie, Guizhou, China
    Center for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023

Diphtheria, Tetanus, Pertussis Trial in Xi'an (Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined

Not yet recruiting
  • Diphtheria
  • +2 more
  • Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp)
  • +2 more
  • Xi'an, Shanxi, China
    Shaanxi Center for Disease Control and Prevention
Sep 25, 2023

Tetanus Trial in Shangqiu (Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed)

Recruiting
  • Tetanus
  • Investigational tetanus vaccine, adsorbed
  • Control tetanus vaccine, adsorbed
  • Shangqiu, Henan, China
    Liangyuan District Center for Disease Control and Prevention
Sep 15, 2023

Tetanus Trial in Ho Chi Minh City (Real-time AI-assisted muscle ultrasound)

Recruiting
  • Tetanus
  • Real-time AI-assisted muscle ultrasound
  • Ho Chi Minh City, Vietnam
    Hospital for Tropical Diseases at Ho Chi Minh city
Sep 10, 2023

Diphtheria, Tetanus, Pertussis Trial (DTaP-HepB-IPV-Hib vaccine)

Not yet recruiting
  • Diphtheria
  • +5 more
  • DTaP-HepB-IPV-Hib vaccine
  • (no location specified)
Jul 11, 2023

Tetanus Trial in China (TNM002, Human tetanus immunoglobulin (HTIG))

Recruiting
  • Tetanus
  • TNM002
  • Human tetanus immunoglobulin (HTIG)
  • Hefei, Anhui, China
  • +29 more
Jan 19, 2023

Tetanus Trial in Minneapolis (incobotulinum toxin A, Placebo-Saline)

Not yet recruiting
  • Tetanus
  • incobotulinum toxin A
  • Placebo-Saline
  • Minneapolis, Minnesota
    University of Minnesota
Dec 6, 2022

Tetanus Trial in China (TNM002 (low dose), TNM002 (medium dose), TNM002 (high dose))

Completed
  • Tetanus
  • TNM002 (low dose)
  • +4 more
  • Shantou, Guangdong, China
  • +3 more
Nov 20, 2022

Diphtheria, Tetanus Trial (Clodivac, Td-Impfstoff Merieux)

Not yet recruiting
  • Diphtheria
  • Tetanus
  • Clodivac
  • Td-Impfstoff Merieux
  • (no location specified)
Aug 9, 2022

Diphtheria, Tetanus, Pertussis Trial (LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin

Not yet recruiting
  • Diphtheria
  • +5 more
  • LBVD (Hexavalent vaccine)
  • Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)
  • (no location specified)
Jul 13, 2022

Program to Determine Product Specific Rates of Invasive Hib

Completed
  • Haemophilus Infections
  • +4 more
  • DTaP-IPV/Hib
  • Albany, California
  • +58 more
Apr 21, 2022

Diphtheria, Tetanus, Pertussis Trial in Soweto (Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine)

Completed
  • Diphtheria
  • +5 more
  • Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
  • Soweto, South Africa
    (unnamed)
Mar 24, 2022

Diphtheria, Tetanus, Pertussis Trial in Thai Binh (Hexaxim®)

Completed
  • Diphtheria
  • +5 more
  • Hexaxim®
  • Thai Binh, Vietnam
    Preventive Medicine Centre of Thai Binh Province
Mar 24, 2022

Diphtheria, Tetanus, Pertussis Trial in Seoul (TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and

Completed
  • Diphtheria
  • +3 more
  • TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
  • Seoul, Korea, Republic of
    (unnamed)
Mar 15, 2022

Tetanus, Diphtheria, Pertussis Trial in United States (Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis

Completed
  • Tetanus
  • +3 more
  • Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1
  • +5 more
  • Birmingham, Alabama
  • +19 more
Mar 15, 2022

Tetanus Trial in Eagle Pass, Laredo (Adacel)

Completed
  • Tetanus
  • Adacel
  • Eagle Pass, Texas
  • +1 more
Dec 15, 2021

Whooping Cough, Diphtheria, Tetanus Trial in China (Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined

Recruiting
  • Whooping Cough
  • +2 more
  • Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
  • +2 more
  • Anyang, Henan, China
  • +3 more
Oct 26, 2021

Diphtheria, Tetanus, Pertussis Trial in Xuchang (Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine,

Unknown status
  • Diphtheria
  • +2 more
  • Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
  • +3 more
  • Xuchang, Henan, China
    Changge Center for Disease Control and Prevention
Mar 9, 2021

Tetanus, Poliomyelitis, Haemophilus Influenzae Type b Trial in Norway, Sweden (Blood Sampling)

Completed
  • Tetanus
  • +6 more
  • Blood Sampling
  • Morvik, Norway
  • +3 more
Jan 12, 2021

Diphtheria, Tetanus Trial in Korea, Republic of (BR-TD-1001, Td-pur inj)

Completed
  • Diphtheria
  • Tetanus
  • BR-TD-1001
  • Td-pur inj
  • Changwon, Korea, Republic of
  • +8 more
Nov 18, 2020

Tetanus, Diphtheria, Pertussis Trial in Fukuoka-shi (DPT-IPV-Hib, Hib vaccine, DPT-IPV)

Completed
  • Tetanus
  • +4 more
  • DPT-IPV-Hib
  • +2 more
  • Fukuoka-shi, Fukuoka, Japan
    Investigational Site
Nov 11, 2020

Diphtheria, Tetanus, Pertussis Trial in Korea, Republic of (DTaP-IPV combination vaccine)

Unknown status
  • Diphtheria
  • +3 more
  • DTaP-IPV combination vaccine
  • Ansan, Korea, Republic of
  • +25 more
Nov 1, 2020

Acellular Pertussis, Hepatitis B, Haemophilus Influenzae Type b Trial in Dominican Republic, Finland (Infanrix hexa, Prevenar

Completed
  • Acellular Pertussis
  • +5 more
  • Infanrix hexa
  • +2 more
  • Santo Domingo, Distrito Nacional, Dominican Republic
  • +15 more
Jul 3, 2020

Tetanus Trial in Ho Chi Minh (Human tetanus immunoglobulin, Intramuscular antitoxin)

Completed
  • Tetanus
  • Human tetanus immunoglobulin
  • Intramuscular antitoxin
  • Ho Chi Minh, Vietnam
    Hospital for Tropical Diseases
May 28, 2020